Nanoparticle-Based Drug Delivery Systems for Photodynamic Therapy of Metastatic Melanoma: A Review

Metastatic melanoma (MM) is a skin malignancy arising from melanocytes, the incidence of which has been rising in recent years. It poses therapeutic challenges due to its resistance to chemotherapeutic drugs and radiation therapy. Photodynamic therapy (PDT) is an alternative non-invasive modality th...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Nkune Williams Nkune, Heidi Abrahamse
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/08b9b6bb4d8542df827041990d776da7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:08b9b6bb4d8542df827041990d776da7
record_format dspace
spelling oai:doaj.org-article:08b9b6bb4d8542df827041990d776da72021-11-25T17:57:43ZNanoparticle-Based Drug Delivery Systems for Photodynamic Therapy of Metastatic Melanoma: A Review10.3390/ijms2222125491422-00671661-6596https://doaj.org/article/08b9b6bb4d8542df827041990d776da72021-11-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/22/12549https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067Metastatic melanoma (MM) is a skin malignancy arising from melanocytes, the incidence of which has been rising in recent years. It poses therapeutic challenges due to its resistance to chemotherapeutic drugs and radiation therapy. Photodynamic therapy (PDT) is an alternative non-invasive modality that requires a photosensitizer (PS), specific wavelength of light, and molecular oxygen. Several studies using conventional PSs have highlighted the need for improved PSs for PDT applications to achieve desired therapeutic outcomes. The incorporation of nanoparticles (NPs) and targeting moieties in PDT have appeared as a promising strategy to circumvent various drawbacks associated with non-specific toxicity, poor water solubility, and low bioavailability of the PSs at targeted tissues. Currently, most studies investigating new developments rely on two-dimensional (2-D) monocultures, which fail to accurately mimic tissue complexity. Therefore, three-dimensional (3-D) cell cultures are ideal models to resemble tumor tissue in terms of architectural and functional properties. This review examines various PS drugs, as well as passive and active targeted PS nanoparticle-mediated platforms for PDT treatment of MM on 2-D and 3-D models. The overall findings of this review concluded that very few PDT studies have been conducted within 3-D models using active PS nanoparticle-mediated platforms, and so require further investigation.Nkune Williams NkuneHeidi AbrahamseMDPI AGarticlemetastatic melanomaphotodynamic therapypassive or active targeted deliveryPS nanoparticle-mediated platformsthree-dimensional (3-D) cell culturesBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 12549, p 12549 (2021)
institution DOAJ
collection DOAJ
language EN
topic metastatic melanoma
photodynamic therapy
passive or active targeted delivery
PS nanoparticle-mediated platforms
three-dimensional (3-D) cell cultures
Biology (General)
QH301-705.5
Chemistry
QD1-999
spellingShingle metastatic melanoma
photodynamic therapy
passive or active targeted delivery
PS nanoparticle-mediated platforms
three-dimensional (3-D) cell cultures
Biology (General)
QH301-705.5
Chemistry
QD1-999
Nkune Williams Nkune
Heidi Abrahamse
Nanoparticle-Based Drug Delivery Systems for Photodynamic Therapy of Metastatic Melanoma: A Review
description Metastatic melanoma (MM) is a skin malignancy arising from melanocytes, the incidence of which has been rising in recent years. It poses therapeutic challenges due to its resistance to chemotherapeutic drugs and radiation therapy. Photodynamic therapy (PDT) is an alternative non-invasive modality that requires a photosensitizer (PS), specific wavelength of light, and molecular oxygen. Several studies using conventional PSs have highlighted the need for improved PSs for PDT applications to achieve desired therapeutic outcomes. The incorporation of nanoparticles (NPs) and targeting moieties in PDT have appeared as a promising strategy to circumvent various drawbacks associated with non-specific toxicity, poor water solubility, and low bioavailability of the PSs at targeted tissues. Currently, most studies investigating new developments rely on two-dimensional (2-D) monocultures, which fail to accurately mimic tissue complexity. Therefore, three-dimensional (3-D) cell cultures are ideal models to resemble tumor tissue in terms of architectural and functional properties. This review examines various PS drugs, as well as passive and active targeted PS nanoparticle-mediated platforms for PDT treatment of MM on 2-D and 3-D models. The overall findings of this review concluded that very few PDT studies have been conducted within 3-D models using active PS nanoparticle-mediated platforms, and so require further investigation.
format article
author Nkune Williams Nkune
Heidi Abrahamse
author_facet Nkune Williams Nkune
Heidi Abrahamse
author_sort Nkune Williams Nkune
title Nanoparticle-Based Drug Delivery Systems for Photodynamic Therapy of Metastatic Melanoma: A Review
title_short Nanoparticle-Based Drug Delivery Systems for Photodynamic Therapy of Metastatic Melanoma: A Review
title_full Nanoparticle-Based Drug Delivery Systems for Photodynamic Therapy of Metastatic Melanoma: A Review
title_fullStr Nanoparticle-Based Drug Delivery Systems for Photodynamic Therapy of Metastatic Melanoma: A Review
title_full_unstemmed Nanoparticle-Based Drug Delivery Systems for Photodynamic Therapy of Metastatic Melanoma: A Review
title_sort nanoparticle-based drug delivery systems for photodynamic therapy of metastatic melanoma: a review
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/08b9b6bb4d8542df827041990d776da7
work_keys_str_mv AT nkunewilliamsnkune nanoparticlebaseddrugdeliverysystemsforphotodynamictherapyofmetastaticmelanomaareview
AT heidiabrahamse nanoparticlebaseddrugdeliverysystemsforphotodynamictherapyofmetastaticmelanomaareview
_version_ 1718411783304118272